This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters To the Editor

Extrapyramidal Side Effects Associated With Aripiprazole Coprescription in 2 Patients

S. Tziporah Cohen, MD; Daphne Rulf, MD; and Ronald Pies, MD

Published: January 15, 2005

Article Abstract

Because this does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Aripiprazole, a novel atypical antipsychotic with a unique mechanism of action,1-3 appears to be effective and well tolerated in most schizophrenic patients.2 However, there has been little systematic investigation of aripiprazole’s pharmacodynamic properties and side effect profile in the presence of other psychotropic agents, particularly in nonschizophrenic individuals.’ ‹’ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 66

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Young-Adult Social Outcomes of Attention-Deficit/Hyperactivity Disorder

ADHD that persisted into young-adulthood was associated with poorer outcomes in terms of education, employment, and emotional...